News and Press Releases
About the CF Foundation | Research | Drug Pipeline CF Foundation Announces Unprecedented Acceleration and Expansion of CF Research, Care and Patient Programs

The Cystic Fibrosis Foundation today announced an unprecedented acceleration and expansion of its research, care and patient programs for the CF community. This action is possible as a result of the sale of the Foundation's royalty rights to CF treatments developed by Vertex Pharmaceuticals Inc. The Foundation received $3.3 billion from the sale to Royalty Pharma.

Nov. 19, 2014 | 3 min read
About the CF Foundation | Public Policy | Drug Pipeline CF Foundation Featured at Congressional Hearing on Patients’ Involvement in Drug Development

CF Foundation President and CEO Robert J. Beall, Ph.D. testified today before the House of Representatives' Energy and Commerce Committee at a hearing entitled, “21st Century Cures: Incorporating the Patient Perspective.”

July 11, 2014 | 2 min read